Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leishmaniasis, Visceral | 17 | 2014 | 94 | 2.780 |
Why?
|
Chagas Disease | 20 | 2022 | 166 | 2.750 |
Why?
|
Trypanosoma cruzi | 18 | 2022 | 198 | 1.970 |
Why?
|
Chagas Cardiomyopathy | 7 | 2015 | 72 | 1.020 |
Why?
|
Dracunculiasis | 3 | 2008 | 12 | 0.830 |
Why?
|
Malaria, Vivax | 3 | 2014 | 173 | 0.770 |
Why?
|
Plasmodium vivax | 4 | 2014 | 208 | 0.750 |
Why?
|
Trypanocidal Agents | 3 | 2020 | 38 | 0.730 |
Why?
|
Nitroimidazoles | 3 | 2020 | 106 | 0.670 |
Why?
|
Leishmaniasis, Cutaneous | 5 | 2021 | 124 | 0.660 |
Why?
|
Insect Vectors | 6 | 2015 | 134 | 0.660 |
Why?
|
Triatoma | 3 | 2015 | 13 | 0.640 |
Why?
|
Leishmania infantum | 3 | 2014 | 17 | 0.630 |
Why?
|
Insect Control | 3 | 2015 | 28 | 0.630 |
Why?
|
Endemic Diseases | 7 | 2009 | 182 | 0.620 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2017 | 39 | 0.610 |
Why?
|
Histoplasma | 1 | 2017 | 41 | 0.610 |
Why?
|
Color Vision Defects | 1 | 2017 | 28 | 0.610 |
Why?
|
Primaquine | 2 | 2014 | 28 | 0.600 |
Why?
|
Histoplasmosis | 1 | 2017 | 66 | 0.600 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2017 | 195 | 0.540 |
Why?
|
Plasmodium | 2 | 2014 | 250 | 0.540 |
Why?
|
Dog Diseases | 2 | 2014 | 138 | 0.450 |
Why?
|
Toxoplasmosis | 2 | 2005 | 91 | 0.450 |
Why?
|
Schistosomiasis | 4 | 2007 | 62 | 0.440 |
Why?
|
Antimalarials | 5 | 2014 | 905 | 0.430 |
Why?
|
Antigens, Protozoan | 5 | 2007 | 322 | 0.420 |
Why?
|
Brazil | 20 | 2021 | 1270 | 0.380 |
Why?
|
Immunocompromised Host | 2 | 2009 | 847 | 0.380 |
Why?
|
Disease Outbreaks | 7 | 2006 | 1772 | 0.360 |
Why?
|
Cat Diseases | 1 | 2009 | 35 | 0.360 |
Why?
|
Bangladesh | 9 | 2013 | 687 | 0.360 |
Why?
|
Leishmania braziliensis | 2 | 2021 | 15 | 0.330 |
Why?
|
Prosthesis-Related Infections | 3 | 2020 | 538 | 0.330 |
Why?
|
Health Facility Administration | 1 | 2008 | 31 | 0.330 |
Why?
|
Travel | 7 | 2017 | 788 | 0.330 |
Why?
|
Zoonoses | 1 | 2009 | 185 | 0.320 |
Why?
|
Albendazole | 2 | 2008 | 33 | 0.320 |
Why?
|
Life Cycle Stages | 3 | 2017 | 160 | 0.320 |
Why?
|
Strongyloidiasis | 1 | 2007 | 27 | 0.310 |
Why?
|
Taeniasis | 2 | 2005 | 15 | 0.310 |
Why?
|
Parotitis | 1 | 2007 | 29 | 0.300 |
Why?
|
Antibodies, Protozoan | 7 | 2011 | 253 | 0.300 |
Why?
|
Refugees | 3 | 2008 | 511 | 0.290 |
Why?
|
Cyclosporiasis | 2 | 2005 | 3 | 0.280 |
Why?
|
Antiprotozoal Agents | 6 | 2013 | 86 | 0.280 |
Why?
|
Antifungal Agents | 2 | 2002 | 730 | 0.270 |
Why?
|
Skin Tests | 2 | 2006 | 613 | 0.270 |
Why?
|
Malaria, Falciparum | 6 | 2010 | 1077 | 0.260 |
Why?
|
Antiparasitic Agents | 1 | 2005 | 41 | 0.260 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2005 | 54 | 0.260 |
Why?
|
Communicable Diseases | 2 | 2009 | 880 | 0.250 |
Why?
|
Anticestodal Agents | 1 | 2004 | 3 | 0.240 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2022 | 1320 | 0.240 |
Why?
|
Abdominal Pain | 2 | 2008 | 1063 | 0.240 |
Why?
|
Radioactive Hazard Release | 1 | 2004 | 14 | 0.240 |
Why?
|
Leishmaniasis, Mucocutaneous | 1 | 2003 | 12 | 0.240 |
Why?
|
Guatemala | 3 | 2015 | 142 | 0.240 |
Why?
|
Arthritis, Infectious | 2 | 2020 | 367 | 0.240 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2002 | 657 | 0.240 |
Why?
|
Gingival Diseases | 1 | 2003 | 34 | 0.240 |
Why?
|
Influenza Vaccines | 2 | 2012 | 738 | 0.230 |
Why?
|
Women's Health Services | 1 | 2004 | 93 | 0.230 |
Why?
|
Rural Population | 9 | 2005 | 2210 | 0.230 |
Why?
|
Preventive Health Services | 1 | 2008 | 575 | 0.230 |
Why?
|
Palate | 1 | 2003 | 123 | 0.230 |
Why?
|
Neurocysticercosis | 1 | 2004 | 62 | 0.220 |
Why?
|
Oral Ulcer | 1 | 2003 | 96 | 0.220 |
Why?
|
Indians, South American | 2 | 1999 | 36 | 0.220 |
Why?
|
Cyclospora | 1 | 2002 | 1 | 0.210 |
Why?
|
Leishmania major | 1 | 2002 | 57 | 0.210 |
Why?
|
Leishmania | 2 | 2008 | 64 | 0.200 |
Why?
|
Fluconazole | 1 | 2002 | 146 | 0.200 |
Why?
|
Humans | 114 | 2023 | 744343 | 0.200 |
Why?
|
Sudan | 3 | 2007 | 83 | 0.200 |
Why?
|
Trypanosomiasis, African | 2 | 2008 | 28 | 0.200 |
Why?
|
Disease Transmission, Infectious | 1 | 2006 | 547 | 0.190 |
Why?
|
Hemorrhagic Fever, American | 1 | 2000 | 12 | 0.190 |
Why?
|
Bursitis | 1 | 2021 | 83 | 0.190 |
Why?
|
Malaria | 4 | 2010 | 1239 | 0.180 |
Why?
|
Animals | 47 | 2015 | 168757 | 0.180 |
Why?
|
Lymphatic Diseases | 2 | 1995 | 324 | 0.180 |
Why?
|
Insecticides | 2 | 2014 | 195 | 0.180 |
Why?
|
Dental Caries | 1 | 2004 | 415 | 0.180 |
Why?
|
Chloroquine | 3 | 2014 | 280 | 0.180 |
Why?
|
Adult | 54 | 2023 | 214055 | 0.180 |
Why?
|
Methylprednisolone | 1 | 2021 | 387 | 0.180 |
Why?
|
Dogs | 5 | 2014 | 3912 | 0.170 |
Why?
|
Amebiasis | 3 | 2005 | 34 | 0.170 |
Why?
|
Amphotericin B | 1 | 1999 | 137 | 0.170 |
Why?
|
Plasmodium falciparum | 6 | 2010 | 1732 | 0.170 |
Why?
|
Brain Diseases | 2 | 2004 | 1563 | 0.170 |
Why?
|
Child, Preschool | 23 | 2013 | 41006 | 0.160 |
Why?
|
Onchocerciasis | 2 | 2007 | 24 | 0.160 |
Why?
|
Disease Vectors | 2 | 2014 | 60 | 0.160 |
Why?
|
Pharmacy and Therapeutics Committee | 1 | 1998 | 9 | 0.160 |
Why?
|
Molecular Epidemiology | 2 | 2019 | 468 | 0.160 |
Why?
|
Carrier State | 1 | 2002 | 518 | 0.160 |
Why?
|
Dengue | 1 | 2021 | 256 | 0.160 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1863 | 0.150 |
Why?
|
Itraconazole | 1 | 2017 | 43 | 0.150 |
Why?
|
Bolivia | 2 | 2009 | 19 | 0.150 |
Why?
|
Prevalence | 10 | 2023 | 15226 | 0.150 |
Why?
|
Phenytoin | 2 | 1988 | 197 | 0.150 |
Why?
|
Bronchoalveolar Lavage | 1 | 2017 | 120 | 0.150 |
Why?
|
Child | 34 | 2013 | 77709 | 0.150 |
Why?
|
Sodium Chloride | 1 | 1999 | 625 | 0.150 |
Why?
|
Babesia microti | 1 | 2017 | 31 | 0.150 |
Why?
|
Infant | 18 | 2022 | 35136 | 0.140 |
Why?
|
Knee Prosthesis | 1 | 2020 | 425 | 0.140 |
Why?
|
Dark Adaptation | 1 | 2017 | 219 | 0.140 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12959 | 0.140 |
Why?
|
Pulmonary Edema | 1 | 1999 | 414 | 0.140 |
Why?
|
Female | 49 | 2023 | 380194 | 0.140 |
Why?
|
Ghana | 2 | 2008 | 286 | 0.140 |
Why?
|
Fever | 2 | 2014 | 1616 | 0.140 |
Why?
|
Leishmaniasis | 2 | 2008 | 47 | 0.140 |
Why?
|
Babesiosis | 1 | 2017 | 92 | 0.140 |
Why?
|
Electroretinography | 1 | 2017 | 509 | 0.130 |
Why?
|
Honduras | 1 | 2015 | 36 | 0.130 |
Why?
|
Disease Reservoirs | 2 | 2010 | 131 | 0.130 |
Why?
|
El Salvador | 1 | 2015 | 39 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 3870 | 0.130 |
Why?
|
Hospitals, Urban | 1 | 1998 | 499 | 0.130 |
Why?
|
Influenza, Human | 1 | 2007 | 1479 | 0.130 |
Why?
|
Consanguinity | 1 | 2017 | 454 | 0.130 |
Why?
|
Male | 52 | 2023 | 350118 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 57 | 0.130 |
Why?
|
Splenectomy | 1 | 2017 | 395 | 0.130 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 142 | 0.130 |
Why?
|
Lymph Nodes | 2 | 2017 | 3474 | 0.130 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 119 | 0.130 |
Why?
|
Incidence | 11 | 2014 | 20947 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.120 |
Why?
|
Adolescent | 27 | 2013 | 85781 | 0.120 |
Why?
|
Women's Health | 1 | 2004 | 2034 | 0.120 |
Why?
|
Polymerase Chain Reaction | 6 | 2009 | 6171 | 0.120 |
Why?
|
Serologic Tests | 2 | 2007 | 374 | 0.120 |
Why?
|
Socioeconomic Factors | 5 | 2006 | 7785 | 0.110 |
Why?
|
Mutation | 2 | 2017 | 29786 | 0.110 |
Why?
|
Surgical Mesh | 1 | 1996 | 276 | 0.110 |
Why?
|
Surgical Wound Infection | 2 | 1996 | 1540 | 0.110 |
Why?
|
Siblings | 1 | 2017 | 854 | 0.110 |
Why?
|
Hypolipidemic Agents | 4 | 1990 | 604 | 0.110 |
Why?
|
Sex Distribution | 4 | 2006 | 2297 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 1170 | 0.110 |
Why?
|
Models, Statistical | 2 | 2012 | 5102 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.110 |
Why?
|
Electrocardiography | 9 | 2011 | 6442 | 0.110 |
Why?
|
Abdominal Injuries | 1 | 1996 | 352 | 0.110 |
Why?
|
Lung Diseases, Parasitic | 1 | 1991 | 14 | 0.100 |
Why?
|
Schistosoma mansoni | 4 | 2007 | 149 | 0.100 |
Why?
|
United States | 13 | 2022 | 69872 | 0.100 |
Why?
|
Health Behavior | 1 | 2004 | 2636 | 0.100 |
Why?
|
Medically Underserved Area | 2 | 2004 | 253 | 0.100 |
Why?
|
Protozoan Proteins | 3 | 2007 | 827 | 0.100 |
Why?
|
Bone Screws | 1 | 1995 | 520 | 0.100 |
Why?
|
Middle Aged | 32 | 2023 | 213383 | 0.100 |
Why?
|
Seizures | 1 | 2004 | 2859 | 0.100 |
Why?
|
Anthelmintics | 2 | 2008 | 62 | 0.100 |
Why?
|
Lung Diseases, Fungal | 1 | 1991 | 122 | 0.100 |
Why?
|
Photic Stimulation | 1 | 2017 | 2025 | 0.100 |
Why?
|
DNA, Protozoan | 2 | 2009 | 237 | 0.090 |
Why?
|
Immunoglobulin G | 5 | 2012 | 4560 | 0.090 |
Why?
|
Phenobarbital | 2 | 1990 | 193 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1906 | 0.090 |
Why?
|
Barbiturates | 1 | 1990 | 114 | 0.090 |
Why?
|
Electromyography | 1 | 1995 | 1379 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 1995 | 1206 | 0.090 |
Why?
|
Macular Degeneration | 1 | 2017 | 980 | 0.090 |
Why?
|
Animals, Domestic | 2 | 2011 | 56 | 0.090 |
Why?
|
Altitude | 2 | 2004 | 161 | 0.090 |
Why?
|
Cluster Analysis | 4 | 2009 | 2715 | 0.090 |
Why?
|
Risk Factors | 13 | 2020 | 72290 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1462 | 0.090 |
Why?
|
Poisson Distribution | 2 | 2008 | 513 | 0.090 |
Why?
|
Togo | 1 | 2008 | 9 | 0.090 |
Why?
|
Seasons | 3 | 2010 | 1493 | 0.090 |
Why?
|
Surgery, Plastic | 1 | 2016 | 624 | 0.090 |
Why?
|
Hip Prosthesis | 1 | 1995 | 917 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2012 | 2026 | 0.080 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1458 | 0.080 |
Why?
|
Catechols | 1 | 1988 | 61 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.080 |
Why?
|
Pyrethrins | 1 | 2008 | 47 | 0.080 |
Why?
|
Emigration and Immigration | 1 | 1991 | 404 | 0.080 |
Why?
|
Parasite Egg Count | 3 | 2006 | 27 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2007 | 401 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 1995 | 957 | 0.080 |
Why?
|
Kidney Diseases | 1 | 1999 | 2149 | 0.080 |
Why?
|
Cats | 1 | 2009 | 998 | 0.080 |
Why?
|
Parasitemia | 3 | 2009 | 174 | 0.080 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 257 | 0.080 |
Why?
|
Onchocerca volvulus | 1 | 2007 | 12 | 0.080 |
Why?
|
Schistosoma haematobium | 1 | 2007 | 11 | 0.080 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2012 | 459 | 0.080 |
Why?
|
Wolbachia | 1 | 2007 | 21 | 0.080 |
Why?
|
Antigens, Helminth | 1 | 2007 | 64 | 0.080 |
Why?
|
Helminthiasis | 1 | 2008 | 66 | 0.080 |
Why?
|
Somalia | 1 | 2007 | 77 | 0.080 |
Why?
|
Aged | 23 | 2021 | 163280 | 0.080 |
Why?
|
Urban Population | 3 | 2006 | 2021 | 0.080 |
Why?
|
Dermatitis, Contact | 1 | 1987 | 129 | 0.070 |
Why?
|
Leishmania mexicana | 1 | 2006 | 31 | 0.070 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2008 | 367 | 0.070 |
Why?
|
Joint Prosthesis | 1 | 1988 | 258 | 0.070 |
Why?
|
Americas | 1 | 2006 | 111 | 0.070 |
Why?
|
Oligodendroglioma | 1 | 2008 | 279 | 0.070 |
Why?
|
Azithromycin | 1 | 2007 | 196 | 0.070 |
Why?
|
Antibodies | 6 | 1987 | 2460 | 0.070 |
Why?
|
Age Factors | 6 | 2020 | 18370 | 0.070 |
Why?
|
Rifampin | 1 | 2007 | 315 | 0.070 |
Why?
|
Ascariasis | 1 | 2005 | 12 | 0.070 |
Why?
|
Loss of Heterozygosity | 1 | 2008 | 684 | 0.070 |
Why?
|
Communicable Disease Control | 2 | 2009 | 857 | 0.070 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 658 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 2011 | 671 | 0.070 |
Why?
|
Spinal Fusion | 1 | 1995 | 1241 | 0.070 |
Why?
|
Trichinellosis | 1 | 2005 | 36 | 0.070 |
Why?
|
Giardiasis | 1 | 2005 | 28 | 0.070 |
Why?
|
Biopsy | 1 | 2017 | 6756 | 0.070 |
Why?
|
Cysticercosis | 1 | 2005 | 34 | 0.060 |
Why?
|
Leishmania donovani | 1 | 2005 | 65 | 0.060 |
Why?
|
Oxamniquine | 4 | 1993 | 4 | 0.060 |
Why?
|
Infant, Newborn | 8 | 2009 | 25625 | 0.060 |
Why?
|
Lobosea | 1 | 2004 | 2 | 0.060 |
Why?
|
Central Nervous System Protozoal Infections | 1 | 2004 | 6 | 0.060 |
Why?
|
Peru | 4 | 2011 | 881 | 0.060 |
Why?
|
Cryptosporidiosis | 1 | 2005 | 60 | 0.060 |
Why?
|
Age Distribution | 3 | 2006 | 2902 | 0.060 |
Why?
|
United Nations | 1 | 2005 | 165 | 0.060 |
Why?
|
Nutrition Disorders | 2 | 2002 | 211 | 0.060 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 270 | 0.060 |
Why?
|
Radioactive Fallout | 1 | 2004 | 8 | 0.060 |
Why?
|
Dental Anxiety | 1 | 2004 | 7 | 0.060 |
Why?
|
Taenia | 1 | 2004 | 17 | 0.060 |
Why?
|
DMF Index | 1 | 2004 | 90 | 0.060 |
Why?
|
Blotting, Southern | 2 | 2002 | 803 | 0.060 |
Why?
|
Awareness | 1 | 2008 | 640 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 1991 | 961 | 0.060 |
Why?
|
Antimony Sodium Gluconate | 1 | 2003 | 10 | 0.060 |
Why?
|
Cameroon | 2 | 1997 | 71 | 0.060 |
Why?
|
Toxoplasma | 1 | 2005 | 150 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2002 | 768 | 0.060 |
Why?
|
Parasites | 1 | 2006 | 163 | 0.060 |
Why?
|
Vitamin A | 1 | 2007 | 615 | 0.060 |
Why?
|
Ukraine | 1 | 2004 | 111 | 0.060 |
Why?
|
Anti-Bacterial Agents | 4 | 2016 | 7181 | 0.060 |
Why?
|
Topography, Medical | 2 | 2009 | 37 | 0.060 |
Why?
|
Feces | 5 | 2006 | 1401 | 0.060 |
Why?
|
Nitriles | 1 | 2008 | 956 | 0.060 |
Why?
|
Anopheles | 2 | 2010 | 197 | 0.060 |
Why?
|
Esophageal Achalasia | 1 | 1984 | 91 | 0.050 |
Why?
|
Zinc | 1 | 2007 | 684 | 0.050 |
Why?
|
Venezuela | 2 | 1999 | 73 | 0.050 |
Why?
|
HIV Infections | 3 | 2012 | 16718 | 0.050 |
Why?
|
DNA, Kinetoplast | 1 | 2002 | 12 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.050 |
Why?
|
Directly Observed Therapy | 1 | 2003 | 137 | 0.050 |
Why?
|
Sex Factors | 3 | 2010 | 10397 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 623 | 0.050 |
Why?
|
Private Sector | 1 | 2005 | 392 | 0.050 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2003 | 137 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14722 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Blastomycosis | 1 | 2001 | 16 | 0.050 |
Why?
|
Climate | 1 | 2002 | 147 | 0.050 |
Why?
|
Hepatitis C | 1 | 2012 | 1591 | 0.050 |
Why?
|
Saudi Arabia | 1 | 2002 | 209 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20129 | 0.050 |
Why?
|
Communicable Diseases, Emerging | 1 | 2003 | 157 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1813 | 0.050 |
Why?
|
Myiasis | 1 | 2001 | 15 | 0.050 |
Why?
|
Geography | 1 | 2003 | 669 | 0.050 |
Why?
|
Transients and Migrants | 1 | 2004 | 155 | 0.050 |
Why?
|
Facial Dermatoses | 1 | 2001 | 87 | 0.050 |
Why?
|
Psychodidae | 1 | 2000 | 24 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3176 | 0.050 |
Why?
|
Encephalitis | 1 | 2004 | 423 | 0.050 |
Why?
|
Reoperation | 2 | 2020 | 4201 | 0.050 |
Why?
|
Agriculture | 1 | 2002 | 190 | 0.050 |
Why?
|
History, 16th Century | 1 | 2000 | 72 | 0.050 |
Why?
|
Digestive System | 1 | 2001 | 253 | 0.050 |
Why?
|
History, 17th Century | 1 | 2000 | 111 | 0.050 |
Why?
|
Melarsoprol | 1 | 1999 | 1 | 0.050 |
Why?
|
Myanmar | 2 | 2010 | 45 | 0.050 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2000 | 66 | 0.050 |
Why?
|
Injections, Intra-Articular | 1 | 2021 | 278 | 0.040 |
Why?
|
Triatominae | 2 | 2011 | 6 | 0.040 |
Why?
|
Enteritis | 1 | 2001 | 165 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2007 | 15540 | 0.040 |
Why?
|
Developing Countries | 3 | 2016 | 2815 | 0.040 |
Why?
|
Hip | 1 | 2021 | 257 | 0.040 |
Why?
|
Information Systems | 1 | 2002 | 410 | 0.040 |
Why?
|
Parasitic Diseases | 2 | 2006 | 75 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3712 | 0.040 |
Why?
|
History, 18th Century | 1 | 2000 | 214 | 0.040 |
Why?
|
Abscess | 2 | 1996 | 607 | 0.040 |
Why?
|
Pregnancy | 4 | 2012 | 29144 | 0.040 |
Why?
|
World Health Organization | 1 | 2005 | 1318 | 0.040 |
Why?
|
Tropical Medicine | 1 | 1999 | 49 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2052 | 0.040 |
Why?
|
Rain | 1 | 1999 | 61 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2012 | 1873 | 0.040 |
Why?
|
Meningeal Arteries | 1 | 1998 | 61 | 0.040 |
Why?
|
Furosemide | 1 | 1999 | 167 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9856 | 0.040 |
Why?
|
Sumatriptan | 1 | 1998 | 65 | 0.040 |
Why?
|
Chronic Disease | 3 | 2006 | 9146 | 0.040 |
Why?
|
Arthrodesis | 1 | 2020 | 189 | 0.040 |
Why?
|
Interdepartmental Relations | 1 | 1998 | 13 | 0.040 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1998 | 115 | 0.040 |
Why?
|
Facility Regulation and Control | 1 | 1998 | 24 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2020 | 214 | 0.040 |
Why?
|
Mexico | 1 | 2000 | 690 | 0.040 |
Why?
|
Education, Pharmacy | 1 | 1998 | 35 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 1998 | 201 | 0.040 |
Why?
|
Logistic Models | 2 | 2007 | 13408 | 0.040 |
Why?
|
Demography | 1 | 2002 | 1656 | 0.040 |
Why?
|
Linear Models | 2 | 2008 | 5952 | 0.040 |
Why?
|
History, 19th Century | 1 | 2000 | 720 | 0.040 |
Why?
|
Community Health Services | 1 | 2003 | 650 | 0.040 |
Why?
|
Formularies as Topic | 1 | 1998 | 91 | 0.040 |
Why?
|
Onchocerciasis, Ocular | 1 | 1997 | 7 | 0.040 |
Why?
|
Time Factors | 4 | 2009 | 40075 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 1998 | 299 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2007 | 57776 | 0.040 |
Why?
|
Program Evaluation | 1 | 2005 | 2488 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2009 | 63114 | 0.040 |
Why?
|
Regression Analysis | 2 | 2007 | 6459 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 1998 | 245 | 0.040 |
Why?
|
Breast Feeding | 1 | 2005 | 1338 | 0.040 |
Why?
|
Diuretics | 1 | 1999 | 592 | 0.030 |
Why?
|
Cost of Illness | 1 | 2006 | 1859 | 0.030 |
Why?
|
Fruit | 1 | 2002 | 1142 | 0.030 |
Why?
|
Rats, Inbred Strains | 4 | 1990 | 2186 | 0.030 |
Why?
|
Certification | 1 | 1999 | 424 | 0.030 |
Why?
|
Vaccination | 1 | 2008 | 3278 | 0.030 |
Why?
|
Health Education | 1 | 2002 | 1056 | 0.030 |
Why?
|
Urinary Diversion | 1 | 1996 | 138 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3778 | 0.030 |
Why?
|
Organizational Policy | 1 | 1998 | 429 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 1998 | 642 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 1983 | 2268 | 0.030 |
Why?
|
Spinal Nerve Roots | 1 | 1995 | 121 | 0.030 |
Why?
|
Toxoplasmosis, Congenital | 1 | 1994 | 8 | 0.030 |
Why?
|
Accreditation | 1 | 1998 | 450 | 0.030 |
Why?
|
Syndrome | 1 | 2001 | 3251 | 0.030 |
Why?
|
Social Class | 1 | 2004 | 1999 | 0.030 |
Why?
|
Follow-Up Studies | 7 | 2002 | 39050 | 0.030 |
Why?
|
Rural Health | 3 | 2006 | 305 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2008 | 12354 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2003 | 1320 | 0.030 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2003 | 912 | 0.030 |
Why?
|
Hip Joint | 1 | 2021 | 1002 | 0.030 |
Why?
|
Nitroquinolines | 2 | 1986 | 4 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 1998 | 469 | 0.030 |
Why?
|
Ethanol | 1 | 2021 | 1342 | 0.030 |
Why?
|
Trichlorfon | 1 | 1993 | 1 | 0.030 |
Why?
|
Praziquantel | 1 | 1993 | 25 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2004 | 25043 | 0.030 |
Why?
|
Synovitis | 1 | 1995 | 209 | 0.030 |
Why?
|
Pyrimethamine | 2 | 1994 | 97 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2001 | 972 | 0.030 |
Why?
|
Mycobacterium avium Complex | 1 | 1993 | 60 | 0.030 |
Why?
|
Population Surveillance | 3 | 2010 | 2616 | 0.030 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1993 | 76 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2002 | 6365 | 0.030 |
Why?
|
Debridement | 1 | 1996 | 492 | 0.030 |
Why?
|
Hernia, Ventral | 1 | 1996 | 176 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2001 | 990 | 0.030 |
Why?
|
Bruch Membrane | 1 | 1993 | 64 | 0.030 |
Why?
|
Triazoles | 1 | 1998 | 911 | 0.030 |
Why?
|
Radiography | 3 | 2001 | 7023 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2008 | 12245 | 0.030 |
Why?
|
Collagenases | 1 | 2013 | 228 | 0.030 |
Why?
|
Caribbean Region | 1 | 1993 | 194 | 0.030 |
Why?
|
Drug Costs | 1 | 2020 | 1105 | 0.030 |
Why?
|
Odds Ratio | 1 | 2005 | 9849 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12797 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1584 | 0.030 |
Why?
|
Prospective Studies | 6 | 2023 | 53288 | 0.030 |
Why?
|
Latin America | 1 | 1993 | 381 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1991 | 2232 | 0.020 |
Why?
|
Focal Infection | 1 | 1991 | 9 | 0.020 |
Why?
|
Mothers | 1 | 2022 | 2165 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4328 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2006 | 13989 | 0.020 |
Why?
|
Endometritis | 1 | 1991 | 48 | 0.020 |
Why?
|
Indium Radioisotopes | 1 | 1991 | 118 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2001 | 1139 | 0.020 |
Why?
|
Pentetic Acid | 1 | 1991 | 213 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 18111 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4803 | 0.020 |
Why?
|
Drainage | 1 | 2016 | 1142 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1995 | 1641 | 0.020 |
Why?
|
Electric Stimulation | 1 | 1995 | 1767 | 0.020 |
Why?
|
Luminol | 1 | 1989 | 6 | 0.020 |
Why?
|
Sulfadoxine | 1 | 1989 | 49 | 0.020 |
Why?
|
Neonatal Screening | 1 | 1994 | 591 | 0.020 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2009 | 16 | 0.020 |
Why?
|
Mycoses | 1 | 1993 | 376 | 0.020 |
Why?
|
Evoked Potentials | 1 | 1995 | 1056 | 0.020 |
Why?
|
Phospholipids | 1 | 1993 | 784 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 3923 | 0.020 |
Why?
|
Enzymes | 1 | 1990 | 266 | 0.020 |
Why?
|
Tsetse Flies | 1 | 2008 | 6 | 0.020 |
Why?
|
Acute Disease | 1 | 1999 | 7149 | 0.020 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2008 | 6 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 1005 | 0.020 |
Why?
|
Staphylococcal Infections | 2 | 1996 | 1400 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 1991 | 389 | 0.020 |
Why?
|
HIV-2 | 1 | 1989 | 167 | 0.020 |
Why?
|
Autoantibodies | 1 | 2017 | 2035 | 0.020 |
Why?
|
Air Microbiology | 1 | 1988 | 87 | 0.020 |
Why?
|
Acetophenones | 1 | 1988 | 48 | 0.020 |
Why?
|
Phthalimides | 1 | 1988 | 25 | 0.020 |
Why?
|
Population Density | 1 | 2008 | 196 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2002 | 12026 | 0.020 |
Why?
|
Hepatitis B | 1 | 1993 | 695 | 0.020 |
Why?
|
Cambodia | 1 | 2008 | 191 | 0.020 |
Why?
|
Ivermectin | 1 | 2007 | 42 | 0.020 |
Why?
|
Risk Assessment | 2 | 2006 | 23338 | 0.020 |
Why?
|
North Carolina | 1 | 2008 | 315 | 0.020 |
Why?
|
Pyridazines | 1 | 1989 | 202 | 0.020 |
Why?
|
Mephenytoin | 1 | 1987 | 3 | 0.020 |
Why?
|
Hydantoins | 1 | 1987 | 11 | 0.020 |
Why?
|
Malaria Vaccines | 1 | 2008 | 158 | 0.020 |
Why?
|
Triglycerides | 2 | 1993 | 2454 | 0.020 |
Why?
|
Bone Cements | 1 | 1988 | 325 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2008 | 8863 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2008 | 1386 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1998 | 1681 | 0.020 |
Why?
|
Medicine, East Asian Traditional | 1 | 2006 | 17 | 0.020 |
Why?
|
Virus Diseases | 1 | 1993 | 711 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 77449 | 0.020 |
Why?
|
Bacteremia | 1 | 1993 | 962 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5255 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 676 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
Maryland | 1 | 2006 | 276 | 0.020 |
Why?
|
Connecticut | 1 | 2006 | 366 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2559 | 0.020 |
Why?
|
Myositis | 1 | 1988 | 251 | 0.020 |
Why?
|
Schistosomiasis mansoni | 1 | 1986 | 85 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40561 | 0.020 |
Why?
|
Private Practice | 1 | 2006 | 154 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1991 | 810 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 1998 | 1364 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
Biometry | 1 | 2008 | 558 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2007 | 390 | 0.020 |
Why?
|
Boston | 1 | 1998 | 9313 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.020 |
Why?
|
Hepacivirus | 1 | 2012 | 1379 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1995 | 5524 | 0.020 |
Why?
|
Drug Combinations | 1 | 1989 | 1959 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1993 | 1401 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1254 | 0.010 |
Why?
|
Coma | 1 | 2007 | 475 | 0.010 |
Why?
|
Esophageal Diseases | 1 | 1984 | 166 | 0.010 |
Why?
|
Rats | 5 | 1994 | 24260 | 0.010 |
Why?
|
Satellite Communications | 1 | 2002 | 13 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5442 | 0.010 |
Why?
|
Models, Biological | 2 | 2009 | 9583 | 0.010 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2002 | 83 | 0.010 |
Why?
|
Skin | 1 | 1995 | 4364 | 0.010 |
Why?
|
Specimen Handling | 1 | 2006 | 694 | 0.010 |
Why?
|
Senegal | 1 | 2002 | 294 | 0.010 |
Why?
|
Belize | 1 | 2001 | 12 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 410 | 0.010 |
Why?
|
India | 1 | 2007 | 2197 | 0.010 |
Why?
|
Diptera | 1 | 2001 | 53 | 0.010 |
Why?
|
Infection Control | 1 | 2008 | 966 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 1994 | 3587 | 0.010 |
Why?
|
Intestine, Small | 1 | 1987 | 1241 | 0.010 |
Why?
|
California | 1 | 2004 | 1402 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2050 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3527 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1999 | 212 | 0.010 |
Why?
|
Merozoite Surface Protein 1 | 1 | 1999 | 38 | 0.010 |
Why?
|
Massachusetts | 2 | 1989 | 8663 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6489 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2007 | 2309 | 0.010 |
Why?
|
Genes, Protozoan | 1 | 1999 | 163 | 0.010 |
Why?
|
Body Weight | 1 | 1990 | 4669 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT1D | 1 | 1998 | 9 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4186 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 1998 | 33 | 0.010 |
Why?
|
Lipids | 1 | 1990 | 3305 | 0.010 |
Why?
|
Cerebral Palsy | 1 | 1983 | 459 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2007 | 1199 | 0.010 |
Why?
|
Biotransformation | 2 | 1989 | 168 | 0.010 |
Why?
|
Tryptamines | 1 | 1998 | 88 | 0.010 |
Why?
|
Ecosystem | 1 | 2002 | 474 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7322 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1987 | 1889 | 0.010 |
Why?
|
Argentina | 1 | 1998 | 232 | 0.010 |
Why?
|
Crohn Disease | 1 | 1991 | 2303 | 0.010 |
Why?
|
Esophagus | 1 | 1984 | 1019 | 0.010 |
Why?
|
China | 1 | 2003 | 2248 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1994 | 2327 | 0.010 |
Why?
|
Intestinal Absorption | 2 | 1989 | 420 | 0.010 |
Why?
|
Income | 1 | 2006 | 1913 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2003 | 1877 | 0.010 |
Why?
|
Injections, Intravenous | 2 | 1989 | 1420 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6622 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6196 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 56430 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2006 | 2576 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3444 | 0.010 |
Why?
|
Spiramycin | 1 | 1994 | 3 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 1994 | 1537 | 0.010 |
Why?
|
Sulfadiazine | 1 | 1994 | 18 | 0.010 |
Why?
|
Canada | 1 | 1999 | 2065 | 0.010 |
Why?
|
Aging | 1 | 1993 | 8664 | 0.010 |
Why?
|
PC12 Cells | 1 | 1994 | 330 | 0.010 |
Why?
|
Intercellular Junctions | 1 | 1994 | 203 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1993 | 223 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1993 | 156 | 0.010 |
Why?
|
Epilepsy | 1 | 1988 | 3310 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 21746 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 1998 | 11366 | 0.010 |
Why?
|
Leucovorin | 1 | 1994 | 628 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 7913 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3022 | 0.010 |
Why?
|
Electroencephalography | 1 | 1987 | 6150 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10481 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1993 | 277 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2003 | 2708 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.010 |
Why?
|
Cecal Diseases | 1 | 1991 | 51 | 0.010 |
Why?
|
Liver | 1 | 1987 | 7474 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2645 | 0.010 |
Why?
|
Administration, Oral | 2 | 1989 | 3913 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1994 | 518 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1989 | 156 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1100 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1989 | 220 | 0.010 |
Why?
|
Africa, Western | 1 | 1989 | 154 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1989 | 518 | 0.010 |
Why?
|
Suppuration | 1 | 1988 | 56 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 1993 | 1465 | 0.000 |
Why?
|
Retinal Diseases | 1 | 1994 | 683 | 0.000 |
Why?
|
Gallium Radioisotopes | 1 | 1988 | 178 | 0.000 |
Why?
|
Societies, Medical | 1 | 1999 | 3743 | 0.000 |
Why?
|
Solubility | 1 | 1989 | 1085 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1998 | 3107 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2571 | 0.000 |
Why?
|
Isomerism | 1 | 1987 | 201 | 0.000 |
Why?
|
Half-Life | 1 | 1988 | 661 | 0.000 |
Why?
|
Radionuclide Imaging | 1 | 1991 | 2031 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.000 |
Why?
|
Injections, Intraperitoneal | 1 | 1987 | 425 | 0.000 |
Why?
|
Actins | 1 | 1994 | 2121 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1993 | 1257 | 0.000 |
Why?
|
Candidiasis | 1 | 1988 | 366 | 0.000 |
Why?
|
Hepatomegaly | 1 | 1985 | 85 | 0.000 |
Why?
|
Transfection | 1 | 1994 | 5892 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1985 | 78 | 0.000 |
Why?
|
Splenomegaly | 1 | 1985 | 190 | 0.000 |
Why?
|
Gastric Mucosa | 1 | 1988 | 599 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1989 | 1150 | 0.000 |
Why?
|
Neoplasms | 1 | 1993 | 21683 | 0.000 |
Why?
|
Nifurtimox | 1 | 1983 | 13 | 0.000 |
Why?
|
Cell Membrane | 1 | 1994 | 3748 | 0.000 |
Why?
|
Lipoproteins | 1 | 1987 | 878 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1985 | 1799 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1987 | 3129 | 0.000 |
Why?
|
Physical Examination | 1 | 1986 | 1237 | 0.000 |
Why?
|
Reference Values | 1 | 1987 | 4982 | 0.000 |
Why?
|
Fibroblasts | 1 | 1989 | 4161 | 0.000 |
Why?
|
Cholesterol | 1 | 1987 | 2917 | 0.000 |
Why?
|
Protein Binding | 1 | 1989 | 9386 | 0.000 |
Why?
|
Mice | 1 | 1987 | 81183 | 0.000 |
Why?
|